ＴＮＦαインヒビターに対して不十分な反応を示す患者の自己免疫疾患治療法

摘要

The Present application describes therapy with antagonists which bind to B cell surface markers, such as CD20. In particular, the application describes the use of such antagonists to treat autoimmune disease in a mammal who experiences an inadequate response to a TNF-± inhibitor.